Prevalence of Sarcopenia in Geriatric Patients
Prevalence of Sarcopenia in Patients Admitted to a Swiss University Department of Geriatric Medicine
1 other identifier
observational
350
1 country
1
Brief Summary
To assess the prevalence of sarcopenia among inpatients on acute geriatrics and geriatric rehabilitation wards of a Swiss university department of geriatric medicine using the most recent diagnosis definitions from european guidelines.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 10, 2019
CompletedFirst Submitted
Initial submission to the registry
October 7, 2019
CompletedFirst Posted
Study publicly available on registry
October 11, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2019
CompletedDecember 2, 2019
November 1, 2019
2 months
October 7, 2019
November 28, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Presence of Sarcopenia (yes/no)
Using EWGSOP2 cut-off points
Baseline
Muscle quantity, measured by Body Impedance Analysis (kg)
Baseline
Hand Grip Strength (kPa)
Baseline
Gait Speed (m/s)
Baseline
Timed up and go Test (s)
Baseline
Secondary Outcomes (6)
Mini Mental Status (Score range from 0 to 30 Points; higher scores reflect better cognitive status)
Baseline
Nutritional risk Screening (Score range from 0 to 7 Points; higher scores reflect higher risk of malnutrition)
Baseline
Geriatric Depression Scale short version (Score range from 0 to 6 Points; higher scores reflect higher risk of depression)
Baseline
Functional Independence Measure at Admission (Score range from 18 to 126 Points; higher scores reflect better functionality)
Baseline
Calf and Mid-upper arm Circumference (cm)
Baseline
- +1 more secondary outcomes
Eligibility Criteria
The study population will be selected by the University Department of Geriatric Medicine FELIX PLATTER
You may qualify if:
- \- All patients \>65 years old admitted to acute geriatrics and geriatric rehabilitation at the study site
You may not qualify if:
- Lack of informed written consent
- Implanted defibrillation device
- Acute Sepsis, severe volume overload or dehydration
- Life expectancy of \< 3 months according to treating physician
- Unremovable bandages
- Patients in isolation rooms on the ward
- Measurement is not possible due to organizational reasons
- Inability to follow the procedures, e.g. due to language problems, psychological disorders
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Department of Geriatric Medicine FELIX PLATTER
Basel, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dominic K. Bertschi, Dr.
University Department of Geriatric Medicine FELIX PLATTER
- STUDY CHAIR
Caroline Kiss, Dr.
University Department of Geriatric Medicine FELIX PLATTER
- STUDY DIRECTOR
Reto W. Kressig, Prof. Dr.
University Department of Geriatric Medicine FELIX PLATTER
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 7, 2019
First Posted
October 11, 2019
Study Start
September 10, 2019
Primary Completion
October 30, 2019
Study Completion
October 30, 2019
Last Updated
December 2, 2019
Record last verified: 2019-11
Data Sharing
- IPD Sharing
- Will not share